These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11386617)

  • 21. Cardiovascular derangement in septic shock and nitric oxide.
    Lodato RF
    J Crit Care; 1996 Dec; 11(4):151-4. PubMed ID: 8977990
    [No Abstract]   [Full Text] [Related]  

  • 22. Nitric oxide and septic shock.
    Cobb JP; Danner RL
    JAMA; 1996 Apr; 275(15):1192-6. PubMed ID: 8609688
    [No Abstract]   [Full Text] [Related]  

  • 23. Novel agents in the therapy of endotoxic shock.
    Howe LM
    Expert Opin Investig Drugs; 2000 Jun; 9(6):1363-72. PubMed ID: 11060748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: lessons learned from experimental and clinical studies.
    Kilbourn RG; Szabó C; Traber DL
    Shock; 1997 Apr; 7(4):235-46. PubMed ID: 9110408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time-dependent aggravation or attenuation of lipopolysaccharide-induced gastric injury by nitric oxide synthase inhibition.
    Suliburk JW; Helmer KS; Kennison SD; Mercer DW; Robinson EK
    J Surg Res; 2005 Dec; 129(2):265-71. PubMed ID: 16026802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aminoethyl-isothiourea inhibits leukocyte production of reactive oxygen species and proinflammatory cytokines induced by streptococcal cell wall components in human whole blood.
    Saetre T; Kähler H; Foster SJ; Lyberg T
    Shock; 2001 Jun; 15(6):455-60. PubMed ID: 11386618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study.
    Avontuur JA; Tutein Nolthenius RP; van Bodegom JW; Bruining HA
    Crit Care Med; 1998 Apr; 26(4):660-7. PubMed ID: 9559602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Is use of nitric oxide (NO) synthase inhibitors justified for therapy of septic shock?].
    Jonderko G; Marcisz C; Braclik M
    Postepy Hig Med Dosw; 2003; 57(1):67-90. PubMed ID: 12765124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substituted N-phenylisothioureas: potent inhibitors of human nitric oxide synthase with neuronal isoform selectivity.
    Shearer BG; Lee S; Oplinger JA; Frick LW; Garvey EP; Furfine ES
    J Med Chem; 1997 Jun; 40(12):1901-5. PubMed ID: 9191968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Certain S-substituted isothioureas not only inhibit NO synthase catalytic activity but also decrease translation and stability of inducible NO synthase protein.
    Wei LH; Arabolos N; Ignarro LJ
    Nitric Oxide; 1998; 2(3):155-64. PubMed ID: 9731633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specificity of inducible nitric-oxide synthase inhibitors: prospects for their clinical therapy.
    Liu ZQ; Wildhirt SM; Zhou HH
    Zhongguo Yao Li Xue Bao; 1999 Nov; 20(11):1052-6. PubMed ID: 11270974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemopreventive effects of a selective nitric oxide synthase inhibitor on carcinogen-induced rat esophageal tumorigenesis.
    Chen T; Nines RG; Peschke SM; Kresty LA; Stoner GD
    Cancer Res; 2004 May; 64(10):3714-7. PubMed ID: 15150132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beneficial effects of L-canavanine, a selective inhibitor of inducible nitric oxide synthase, on lactate metabolism and muscle high energy phosphates during endotoxic shock in rats.
    Levy B; Valtier M; de Chillou C; Bollaert PE; Cane D; Mallie JP
    Shock; 1999 Feb; 11(2):98-103. PubMed ID: 10030795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beneficial effects of L-canavanine, a selective inhibitor of inducible nitric oxide synthase, during rodent endotoxaemia.
    Liaudet L; Feihl F; Rosselet A; Markert M; Hurni JM; Perret C
    Clin Sci (Lond); 1996 May; 90(5):369-77. PubMed ID: 8665774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitric oxide synthase inhibition by L-NAME in leukocytopenic patients with severe septic shock.
    Kiehl MG; Ostermann H; Meyer J; Kienast J
    Intensive Care Med; 1997 May; 23(5):561-6. PubMed ID: 9201529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of glucocorticoid receptor binding by nitric oxide in endotoxemic rats.
    Duma D; Silva-Santos JE; Assreuy J
    Crit Care Med; 2004 Nov; 32(11):2304-10. PubMed ID: 15640646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of new L-thiocitrulline derivatives as inhibitors of nitric oxide synthase.
    Ware RW; King SB
    Bioorg Med Chem Lett; 2000 Dec; 10(24):2779-81. PubMed ID: 11133090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aminoethyl-isothiourea, a selective inhibitor of inducible nitric oxide synthase activity, improves liver circulation and oxygen metabolism in a porcine model of endotoxemia.
    Saetre T; Gundersen Y; Thiemermann C; Lilleaasen P; Aasen AO
    Shock; 1998 Feb; 9(2):109-15. PubMed ID: 9488255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glabridin, an isoflavan from licorice root, inhibits inducible nitric-oxide synthase expression and improves survival of mice in experimental model of septic shock.
    Kang JS; Yoon YD; Cho IJ; Han MH; Lee CW; Park SK; Kim HM
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1187-94. PubMed ID: 15537821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inducible nitric oxide synthase pathway in the central nervous system and vasopressin release during experimental septic shock.
    Giusti-Paiva A; De Castro M; Antunes-Rodrigues J; Carnio EC
    Crit Care Med; 2002 Jun; 30(6):1306-10. PubMed ID: 12072686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.